Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Disease × Pluvicto × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 39 Metastatic Castration-resistant Prostate Cancer 5 Prostatic Diseases 3 Kidney Neoplasms 3 Urogenital Neoplasms 2 Neoplasms by Site 2 Neoplasms 2 Genital Neoplasms, Male 2 Carcinoma, Renal Cell 2 Prostatic Neoplasms, Castration-Resistant 1 Prostate Cancer Metastatic 1 PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy 1 Neoplasm Metastasis 1 Metastatic Hormone Naive Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer (mCRPC) 1 Metastatic Castration Resistant Prostate Cancer 1 Metastatic Castrate Resistant Prostate Cancer (mCRPC) 1 Male Urogenital Diseases 1 Genital Diseases, Male 1 Disease 1 Clear-cell metastatic renal cell carcinoma 1

Interventions

Blood Specimen Collection 3 Surveys and Questionnaires 2 Prednisone 2 Positron-Emission Tomography 2 Magnetic Resonance Imaging 2 Injections 2 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2 vistusertib 1 pembrolizumab 1 ioflupane 1 gossypol acetic acid 1 carbon-11 acetate 1 abiraterone 1 Urine Specimen Collection 1 Urination 1 Therapeutics 1 Specimen Handling 1 Referral and Consultation 1 Prostatectomy 1 Preoperative Exercise 1 Positron Emission Tomography Computed Tomography 1 Pluvicto 1 Music Therapy 1 Multiparametric Magnetic Resonance Imaging 1 Mitomycin 1 Liquid Biopsy 1 Interviews as Topic 1 Interleukin-15 1 Food 1 Fluorodeoxyglucose F18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07054346 2025-12-01

LUTACT

University of California, San Francisco

Phase 1 Recruiting

Disease, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡